The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I am a cardiovascular physiologist investigating the origin of the large increases in cardiac and renal sympathetic nerve activity in heart failure,the causes of acute renal failure in septic shock and mechanisms to reduce myocardial ischaemia-reperfusion
I am a scientist with a background in molecular and cellular pathology. My research relates to studies of animals models of diabetic kidney and heart disease focusing on the discovery of novel treatments.
Prof Rosenthal proposes to use the Australia Fellowship to create a systems approach to regenerative medicine by bringing today’s breakthroughs in genomics, proteomics, engineering and animal modelling to a critical unanswered biological question: how can we enhance our regenerative capacity in ageing and disease. A successful outcome of this research will pave the way for innovation in clinical treatment of some of the most devastating chronic health problems in Australian society.
I am a cardiovascular clinician-scientist involved in characterising the cellular and molecular pathogenesis of heart failure. My goal is to translate these findings into clinical solutions.
I am a cardiology research scientist investigating the differences between physiological (“good”) and pathological (“bad”) heart growth- cardiac hypertrophy. In general, heart failure research and therapy has concentrated on identifying and inhibiting pathological processes. In contrast, my research is unique because it has focused on activating physiological pathways (elevated in the athlete’s heart) in the failing heart as a potential new strategy for the treatment of heart failure and atrial ....I am a cardiology research scientist investigating the differences between physiological (“good”) and pathological (“bad”) heart growth- cardiac hypertrophy. In general, heart failure research and therapy has concentrated on identifying and inhibiting pathological processes. In contrast, my research is unique because it has focused on activating physiological pathways (elevated in the athlete’s heart) in the failing heart as a potential new strategy for the treatment of heart failure and atrial fibrillation.Read moreRead less
As Director of Research in the Department of Cardiology, Prof Hare supervises a number of research groups, a major one being a “Psychosocial” research group, others including a “wet “ vascular laboratory, a clinical cardio-vascular laboratory, an exercise research group and a clinical trials group primarily working in heart failure.